All Healthcare articles – Page 2
-
White papers
From consumer gadgets to medical devices
The distinction between consumer and healthcare devices is becoming less pronounced in light of a recent trend whereby more consumers are using medically-proven health monitoring tools, and more non-patients are using medical devices. Investors in this market should be aware of how competition is developing.
-
White papers
Consumer demand for the quantified self Consumer demand for the quantified self
The first conventional quantified self device, counting users’ steps over the course of the day, was launched in 2009. Since then, a number of world-leading brands have entered this rapidly-growing market and burgeoning investment trend.
-
White papers
Better health through the quantified self
Better and earlier diagnostics are key to moving from curing disease to preventing sickness entirely. Smart devices and fitness trackers stand to play a significant role in this advancement.
-
Podcast
The uncapped impact series with GreenLight Biosciences
Until recently, humanity has relied on chemical solutions to address its biggest challenges. For example, our ability to grow food, to defend livestock against disease and to safeguard human health, all depend in part on chemical solutions. Today is no different. Yet resistance to chemicals is rising rapidly, exacerbated by climate change and ecosystem degradation.
-
White papers
Life Science in Germany
It is now time to provide a detailed analysis of the real estate sector for life sciences companies. This market segment is attracting everincreasing interest from property developers, investors and financiers. It comes as no surprise that medical technology, pharmaceuticals and biotech companies have gained significant prominence over the last two years in view of their huge contribution to the control of the Covid-19 pandemic.
-
Asset Manager News
Primonial REIM Germany successfully carries out a healthcare real estate transaction on behalf of Primovie, a retail investor fund managed by Primonial REIM France
Primonial REIM Germany today announces that it has acquired Futura III, a seven-asset portfolio in Germany dedicated to assisted living. The seller is Senioren-Wohnen Holding from which an acquisition of a first portfolio was already made in 2019 (Futura I portfolio)
-
Asset Manager News
High-quality senior living a resilient investment underpinned by long-term demand
Recently, Reno Sio, Institutional Real Estate, In’s managing director, Asia Pacific, spoke with Andrew Heithersay, managing director and partner of SC Capital Partners, and Tim Russell, director and co-founder of Aura Holdings. Following is an excerpt of that conversation.
-
White papers
If Sanctions Didn’t Stop the War, They Can Still Shape the Peace
After Ukraine’s allies decide how much to ratchet up pressure on Russia, they will face tough choices on how to ratchet down.
-
White papers
Real Estate in a (More) Fully Funded World
The COVID-19 pandemic will be long and largely negatively remembered.
-
Asset Manager News
KGAL acquires Charles Square Center in Prague
Grünwald, 24.02.2022 – KGAL Investment Management GmbH & Co. KG has acquired the Charles Square Center in Prague, which includes offices, retail, restaurants and healthcare space, on behalf of a pan-European fund. The city centre property with a total of almost 20,000 square metres of leasable space has a roster of international, renowned tenants. The seller was Commerz Real.
-
Video
2022: An even brighter future for disruptive tech
The pandemic has sped up a transformation in technology that would otherwise have taken years, triggering a sea change in how we work, buy and communicate. Advances in, for example, cloud computing, the internet of things and artificial intelligence are affecting industries as diverse as financial services, healthcare and consumer goods and creating opportunities for investors.
-
Video
Synthetic Biology: Investing in the Science of Sustainability
If the technology for making diabetes medicine hadn’t changed since the 1930s, today we’d need an area larger than the surface of the earth for raising pigs, harvesting insulin from their pancreases to help hundreds of millions of diabetics around the world.
-
White papers
Omicron Soon to Be the Dominant Variant in the U.S…Is This Strain the Way Out of the Pandemic?
We thought it might be helpful to frame our latest thinking on the SARS-CoV2 Omicron variant now that we have seen more data out of South Africa on the evolution of this viral variant.
-
White papers
How investing in biotech can help achieve the SDGs
From pioneering therapies to renewable food sources, biotechnology has the potential to address many of humanity’s greatest challenges, as aligned to the United Nations’ Sustainable Development Goals (SDGs).
-
White papers
Omicron: The Reason to Seriously Consider Getting a Third COVID-19 Vaccine Shot
Pfizer data suggests a third dose of Comirnaty (COVID-19 vaccine) appeared to increase neutralizing antibodies 25-fold against the Omicron variant, a level suggesting protective immunity against severe COVID-19.
-
White papers
Geopolitics of the vaccine: variance risks
Covid-19 vaccines have been rolled out for a year now. Despite official commitments to provide access to effective jabs to all countries, production constraints and national priorities have resulted in uneven distribution, with some countries close to 100% vaccination rates while others are still below 5%.
-
Research Report
Real Estate Convictions - November 2021
In a world dominated by uncertainty, the recovery in the global economy continues. With the on-going vaccination of the general population and booster campaigns remaining a strategic priority, to avoid the introduction of new health restrictions that would deteriorate growth in late 2021 and early 2022, the deterioration of short-term prospects has come from China.
-
White papers
Novo Nordisk Throws Its Weight Behind Patients With Obesity And Diabetes
The world’s obesity and sugar-high problems have healthcare budgets bursting at the seams.
-
White papers
Battling the superbugs
Antimicrobial resistance (AMR) is growing, although the risk too often goes unmanaged or ignored. Yet the ramifications for public health are huge.
-
Research Report
Climate crisis in focus in EOS’s Q3 Public Engagement Report
With scientists calling for urgent action on climate change following another year of devastating wildfires and floods, November’s COP26 summit is considered critical.